This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Oct. 25, 2012

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Fall Managed Care Forum
Nov. 8-9
Bellagio Hotel

Now accepting nominations for the Behavioral Health Innovation Award. Please click here to download the application and instructions!

Click Here to view the Journal of Managed Care Medicine

Click Here to view our Complimentary Online CME/CEU Webcasts

Announcing the NAMCP Medical Directors Lung Cancer Resource Center. Click here to visit the website.

Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.

Click here to check out the "Latest in Clinical Nutrition" DVD available for purchase now!



Test your DNA for diseases — No doctor required
TIME    Share    Share on FacebookTwitterShare on LinkedinE-mail article
VideoBriefGenetic tests have been around for years, but in 2003 scientists took the field a step further, announcing the first complete mapping of a human genome — an entire genetic code. Sequencing a person's genome is one of the newest, most controversial tools in the medical arsenal. Even as physicians and bioethicists wrestle with the implications of revealing DNA secrets, entrepreneurs are planning to make whole-genome sequencing available to the public. More

Study finds why Avastin only works in some patients
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Genetic testing could help doctors find the small number of patients with advanced bowel cancer likely to benefit from cancer drug Avastin, scientists said. In a study of Roche's blockbuster drug, which targets and blocks a protein called VEGF-A, researchers found that different forms of the protein lead to varying responses and Avastin had no benefit in at least half of those taking it. More

Earn your MS in Nursing Online

Nursing@Georgetown is a Master’s in Nursing program delivered online by Georgetown University’s renowned School of Nursing & Health Studies. These programs are designed to help the next generation of nursing leaders achieve their career goals while improving the health and well-being of all people. MORE

Will my son get cancer? Sequencing your children's genomes
TIME via CNN    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Can you imagine wanting to know whether your newborn baby will fall victim to Alzheimer's disease decades down the road? What about cancer, or diabetes? When it comes to your health, the debate about how much information is too much is about to get a lot more complicated. Whole genome sequencing, a scientific breakthrough less than 10 years old, is on its way to becoming a mainstream medical test. More

 Biotech/Diagnostics/Personalized Medicine

Targeted breast cancer therapies coming to the forefront in treatment
The Baltimore Sun    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Unlike chemotherapy, which kills all rapidly growing cells, from cancer to bone marrow and hair follicles, targeted cancer therapies hone in on just cancer cells and the molecules that help them multiply and spread. Soon even more targeted therapies — either already approved or about to be — will be available for newly diagnosed breast cancer patients, offering hope that it can become more of a manageable chronic disease and less of a killer. More

Experience Healthy Work-Life Balance

Concentra is a proven leader in occupational medicine, treating 1 in 7 work-related injuries in the US. Concentra physicians work consistent schedules with minimal to no on-call shifts in an environment designed to allow more time for patient care—and more time for a healthy work-life balance.

Personalized medicine research strikes early for heart genes
The Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers have published a landmark paper identifying genetic signatures that predict which patients will respond to a life-saving drug for treating congestive heart failure. The analysis led to a "genetic scorecard" for patients with congestive heart failure, a serious condition in which the heart can't pump enough blood to meet the body's needs, researchers said. More

 Regenerative Medicine

Guide helps stem cell researchers go through approval process
Sacramento Business Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In an effort to help researchers move promising therapies from the laboratory to clinical trials, an executive with the California stem cell agency has written a guide to navigating the approval process. An article in the journal Stem Cells Translational Medicine lays out how to work with the Food and Drug Administration to clear the path. The goal is to help companies understand the complexity of the process and how to get through it quickly. More

What does it mean when athletes get 'stem cell therapy?'
The Atlantic    Share    Share on FacebookTwitterShare on LinkedinE-mail article
One could argue that stem cell research is currently the most promising area of biomedical research. But much of the press coverage associated with the field falls squarely in the too-good-to-be true category. It is this sort of unsubstantiated hype that contributes to inappropriate public expectations and the legitimization of bogus therapies. A new and troubling dimension to the hype has emerged: the well-publicized use of "stem cell therapies" by high-profile athletes. More

 Emerging Medical Technologies

Death by defibrillator: FDA called to address hacking risk
NBC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
According to a recent report by the Government Accountability Office, there's a growing danger that grandpa's heart rhythm device, or, say, a child's insulin pump — any implantable device that can be accessed remotely — could be susceptible to hacking. More

Hospital medical devices riddled with malware
FierceHealthIT    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Hospital equipment increasingly is riddled with malware that could interfere with its operation or change readings, panelists said recently at a meeting of a medical-device panel at the National Institute of Standards and Technology Information Security and Privacy Advisory Board. Though no cases of patient harm have been attributed to it, it's a common problem, one expert said. More

 Managed Healthcare News

Study: Insurers are again selling child-only health policies
Kaiser Health News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
One of the first provisions of the Affordable Care Act to take effect prohibited insurers from turning down children younger than 19 on the grounds they had a pre-existing medical condition. It had a negative effect: Insurers in many states stopped selling child-only policies. That may be changing. A new study found that since the law passed in 2010, 22 states and District have moved to address the problem through new laws or regulations that encourage insurers to sell child-only plans. More

Liability premium relief good for doctors, unsettling for insurers
American Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Small but persistent declines in medical liability insurance premiums have many insurers concerned about the future of their industry. Yet doctors are benefiting from lower rates and rising competition among insurers vying for their business. More

 FDA: New Treatments and Technology

HIV finding opens new path for vaccine research
NPR    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers in South Africa have learned something new about how antibodies fight off HIV in research that could advance the quest to develop a vaccine against the virus. In a paper published in Nature Medicine, researchers from the Centre for the AIDS Programme of Research in South Africa tracked how the evolution of the virus in two infected woman shaped the antibodies they produced to fight it. More

FDA probes reports of deaths linked to energy drinks
The Associated Press via USA Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The highly caffeinated Monster Energy Drink has been cited in five deaths and one non-fatal heart attack, according to reports the Food and Drug Administration is investigating. The reports claim that people had adverse reactions after they consumed Monster Energy Drink, which comes in 24-ounce cans and contains 240 milligrams of caffeine, or seven times the amount of the caffeine in a 12-ounce cola. More

Before meningitis outbreak, pharmacy avoided sanctions
The Associated Press via Salon    Share    Share on FacebookTwitterShare on LinkedinE-mail article
New state documents detail problems found in 2006 by an outside firm hired to do an assessment at the company at the center of a deadly meningitis outbreak. The state documents, obtained by The Associated Press under a public records request, say investigators in 2006 found inadequate contamination control and no written standard operating procedures for using equipment, among other problems, at the New England Compounding Center. More

"According to the American Cancer Society, colorectal cancer is one of the leading causes of cancer-related deaths in the country. Early diagnosis can often lead to a complete cure."


Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Oct. 18, 2012
Oct. 11, 2012
Oct. 4, 2012
Sept. 27, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063